This study will evaluate an innovative multilevel transplant intervention delivered within KPSC, an integrated CKD healthcare delivery system, for earlier stage patients not yet in kidney failure (Stage 3b and 4) as well as for patients whose kidneys have failed. The intervention will target patients, their support networks, potential donors, KPSC clinicians, and the KPSC system as a whole. It will integrate an innovative mHealth CKD education application with updated KPSC CKD care process to educate, empower, and engage patients, potential living donors, and family members in learning more about and pursuing transplant and living donation.
The intervention will be activated across the system by KPSC CKD clinical leadership, with all research and educational components led by the study PIs. Investigators will assess effects of the multilevel intervention on the primary outcome, referral for transplant, and on secondary outcomes including attendance at KPSC education classes, KPSC nephrology visits, level of patient transplant knowledge, wait-listing rates, and DDKT/LDKT rates. Investigators will further analyze trial results, examining heterogeneity of treatment effects and mechanisms of effect.
This study operates under a reliance agreement, with KPSC being the reviewing IRB of record.
